Picture of Kuros Biosciences AG logo

KURN — Kuros Biosciences AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Kuros Biosciences AG Says Appointed Daniel Geiger As Chief Financial Officer (CFO) Ad Interim, Effective February 17, 2023

Feb 16 (Reuters) - Kuros Biosciences AG  KURN.S :
    * DANIEL GEIGER AS CHIEF FINANCIAL OFFICER (CFO) AD INTERIM,
EFFECTIVE FEBRUARY 17, 2023
    * DANIEL GEIGER SUCCEEDS MICHAEL GRAU, WHO WILL HANDOVER HIS
CFO
POSITION

Source text for Eikon:  ID:nEQ68y1Hda 
Further company coverage:  KURN.S 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kuros Biosciences AG

See all news